Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Rapport Therapeutics, Inc. | 393,075 | reported | 19 Feb 2026 | tx 27+237,302−132,567 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Feb 2026 | SALE | Rapport Therapeutics, Inc. | 2,200 | 29.59 USD | |
| 17 Feb 2026 | SALE | Rapport Therapeutics, Inc. | 5,400 | 28.95 USD | |
| 17 Feb 2026 | SALE | Rapport Therapeutics, Inc. | 900 | 28.02 USD | |
| 19 Feb 2026 | EXERCISE | Rapport Therapeutics, Inc. | 6,000 | 1.80 USD | |
| 19 Feb 2026 | EXERCISE | Rapport Therapeutics, Inc. | 6,000 | 0.00 USD | deriv |
| 02 Feb 2026 | GRANT_AWARD | Rapport Therapeutics, Inc. | 103,000 | 0.00 USD | deriv |
| 15 Jan 2026 | SALE | Rapport Therapeutics, Inc. | 8,300 | 26.83 USD | |
| 15 Jan 2026 | SALE | Rapport Therapeutics, Inc. | 200 | 27.40 USD | anomaly |
| 31 Dec 2025 | SALE | Rapport Therapeutics, Inc. | 6,567 | 30.05 USD | |
| 31 Dec 2025 | GRANT_AWARD | Rapport Therapeutics, Inc. | 18,000 | — | |
| 15 Dec 2025 | SALE | Rapport Therapeutics, Inc. | 7,704 | 29.95 USD | |
| 15 Dec 2025 | SALE | Rapport Therapeutics, Inc. | 796 | 30.68 USD | |
| 17 Nov 2025 | SALE | Rapport Therapeutics, Inc. | 5,344 | 25.39 USD | |
| 17 Nov 2025 | SALE | Rapport Therapeutics, Inc. | 3,156 | 24.84 USD | |
| 15 Oct 2025 | SALE | Rapport Therapeutics, Inc. | 1,082 | 26.16 USD | |
| 15 Oct 2025 | SALE | Rapport Therapeutics, Inc. | 7,418 | 25.73 USD | |
| 15 Sept 2025 | SALE | Rapport Therapeutics, Inc. | 5,098 | 23.88 USD | |
| 15 Sept 2025 | SALE | Rapport Therapeutics, Inc. | 3,402 | 24.66 USD | |
| 15 Aug 2025 | SALE | Rapport Therapeutics, Inc. | 8,300 | 14.98 USD | |
| 15 Aug 2025 | SALE | Rapport Therapeutics, Inc. | 200 | 15.79 USD | anomaly |
| 15 Jul 2025 | SALE | Rapport Therapeutics, Inc. | 8,500 | 14.00 USD | |
| 16 Jun 2025 | SALE | Rapport Therapeutics, Inc. | 8,500 | 11.00 USD | |
| 15 May 2025 | SALE | Rapport Therapeutics, Inc. | 8,500 | 9.56 USD | |
| 15 Apr 2025 | SALE | Rapport Therapeutics, Inc. | 8,500 | 9.57 USD | |
| 14 Mar 2025 | SALE | Rapport Therapeutics, Inc. | 8,500 | 10.85 USD |